Australia’s biotech industry is thriving, with ASX-listed companies up 19% since 2019

News
Written By Doron Katz

Australia’s biotech industry is on a strong growth trajectory, having grown more than 40% in two years, with the market cap figure of those listed on the ASX up almost $16 billion in six months.

Read the complete article in Stockhead.

Doron Katz

Software Engineer for over 14 years, and technical project manager for over 4 years.
Author of books such as Continuous Delivery for Mobile (Packt), as well as various LinkedIn Learning video courses.

http://doronkatz.com
Previous

Food tech startup Vow wants to make Australia a world leader in cultured meat
Next

Cheers to Tasmania